|本期目录/Table of Contents|

[1]朱莹,刘正兵,谢亮,等.合并糖尿病的冠状动脉粥样硬化性心脏病患者支架置入术后远期随访 研究[J].国际心血管病杂志,2018,03:176-179.
　ZHU Ying,LIU Zhengbing,XIE Liang,et al.Long-term outcomes after stent implantation in patients with coronary atherosclerotic heart disease and diabetes mellitus[J].International Journal of Cardiovascular Disease,2018,03:176-179.
点击复制

合并糖尿病的冠状动脉粥样硬化性心脏病患者支架置入术后远期随访 研究(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2018年03期
页码:
176-179
栏目:
临床研究
出版日期:
2018-05-25

文章信息/Info

Title:
Long-term outcomes after stent implantation in patients with coronary atherosclerotic heart disease and diabetes mellitus
作者:
朱莹; 刘正兵; 谢亮; 李建华; 何松清; 宫剑滨
210002 中国人民解放军南京总医院心血管内科
Author(s):
ZHU Ying;  LIU Zhengbing;  XIE Liang;  LI Jianhua;  HE Songqing;  GONG Jianbin.
Department of Cardiology, Jinling Hospital, Medical School of Nanjing University, Jiangsu 210000, China
关键词:
冠状动脉粥样硬化性心脏病;  糖尿病;  经皮冠状动脉介入术;  死亡率
Keywords:
Coronary atherosclerotic heart disease;  Diabetes mellitus;  Percutaneous coronary intervention;  Mortality
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2018.03.013
文献标识码:
-
摘要:
目的:评价合并糖尿病的冠状动脉粥样硬化性心脏病(冠心病)患者接受支架置入术后的远期疗效。方法:入选2011年2月至12月行支架置入术的冠心病患者483例,分为糖尿病组(n=138),非糖尿病组(n=345)。所有患者至少随访5年,主要终点事件为全因死亡,复合终点为主要心血管不良事件(MACE),包括心肌梗死、靶血管重建、支架内再狭窄和死亡。结果:随访期间,糖尿病组发生心肌梗死6例、靶血管重建16例、支架内再狭窄6例、死亡12例、总MACE事件30例; 非糖尿病组发生心肌梗死3例
Abstract:
Objective:To assessthe long-term effect of coronary stent implantation in patients with diabetes mellitus.Methods:Four hundred and eighty-three coronary atherosclerotic heart disease(CHD)patients who received percutaneous coronary intervention(PCI)with co

参考文献/References

[1] Silva JA, Escobar A, Collins TJ, et al. Unstable angina. A comparison of angioscopic findings between diabetic and nondiabetic patients[J]. Circulation, 1995, 92(7):1731-1736.
[2] Taubert G, Winkelmann BR, Schleiffer T, et al. Prevalence, predictors, and Consequences of unrecognized diabetes mellitus in 3 266 patients scheduled for coronary angiography[J]. Am Heart J, 2003, 145(2):285-291.
[3] Daemen J, Kuck KH, Macaya C, et al. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-Ⅱ(Arterial Revascularization Therapies Study-Part Ⅱ)trial[J]. J Am Coll Cardiol, 2008, 52(24):1957-1967.
[4] Iijima R, Ndrepepa G, Mehilli J, et al. Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era[J]. Am Heart J, 2007, 154(4):688-693.
[5] Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease[J]. Am J Cardiol, 1983, 51(3):606.
[6] Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis:epidemiology, pathophysiology, and management[J]. JAMA, 2002, 287(19):2570-2581.
[7] 李宏亮, 余叶蓉. 2型糖尿病患者血管内皮细胞功能异常及其机理研究[J]. 中华糖尿病杂志, 2004, 12(2):146-148.
[8] 姜华, 吴建国, 张我素. 冠状动脉粥样硬化性心脏病合并Ⅱ型糖尿病患者冠状动脉病变特点[J]. 中国介入心脏病学杂志, 2000, 8(3):118-120.
[9] Billinger M, Beutler J, Taghetchian KR, et al. Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patients[J]. Eur Heart J, 2008, 29(6):718-725.
[10] Jensen LO, Maeng M, Thayssen P, et al. Long-term outcomes after percutaneous coronary intervention in patients with and without diabetes mellitus in Western Denmark[J]. Am J Cardiol, 2010, 105(11):1513-1519.
[11] Andron M, Perry RA, Egred M, et al. The impact of diabetes mellitus on two-year mortality following contemporary percutaneous coronary intervention:implications for revascularization practice[J]. J Interv Cardiol, 2009, 22(5):420-426.
[12] Megherbi SE, Milan C, Minier D, et al. Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project[J]. Stroke, 2003, 34(3):688-694.
[13] Berry C, Tardif JC, Bourassa MG. Coronary heart disease in patients with diabetes: part Ⅱ: recent advances in coronary revascularization[J]. J Am Coll Cardiol, 2007, 49(6):643-656.
[14] Strojek K, Raz I, Jermendy G, et al. Factors associated with cardiovascular events in patients with type 2 diabetes and acute myocardial infarction[J]. J Clin Endocrinol Metab, 2016, 101(1):243-253.
[15] Mathew V, Frye RL, Lennon R, et al. Comparison of survival after successful percutaneous coronary intervention of patients with diabetes mellitus receiving insulin versus those receiving only diet and/or oral hypoglycemic agents[J]. Am J Cardiol, 2004, 93(4):399-403.

备注/Memo

备注/Memo:
基金项目:南京总医院院管课题(2016030)
通信作者:宫剑滨,Email:jianbingong@163.com
更新日期/Last Update: 2018-06-01